Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Launched in Japan in 2021, anamoline is the world's first drug specifically for the treatment of cachexia; As a ghrelin receptor agonist, it is able to increase the patient'···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：281
Anamorelin is the world's first drug specifically for the treatment of cachexia, launched in Japan in 2021, which significantly improves patients' appetite and weight by ac···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：334
In 2021, Anamorelin was launched in Japan, becoming the world's first drug specifically for the treatment of cachexia. It significantly increases the patient's appetite and···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：229
Designed for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induced hypercortisolism, Mitotane is distinguished by its precise regulation and inhibition of adrenal c···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：260
Mitotane was developed to address inoperable adrenal cortical carcinoma, hyperplasia, and tumor-induced hypercortisolism, and its core mechanism is the careful regulation and inhib···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：278
Mitotaneis specific for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induced cortisol hyperactivity, and its essence lies in the precise inhibition of adrenal cort···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：293
Mitotane is specifically developed for the treatment of inoperable adrenal cortical carcinoma, hyperplasia, and neoplastic hypercortisolism, and its core mechanism of action is to ···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：265
Mitotane is specifically designed for the treatment of inoperable adrenal carcinoma, hyperplasia, and tumor-induced cortisol excess, and its core efficacy lies in the suppression o···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：290
Mitotane is a drug dedicated to the treatment of adrenocortical carcinoma (inoperable), hyperplasia, and tumor-induced hypercortisolism, and its core mechanism is to inhibit adrena···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：290
Mitotaneis a drug used to treat inoperable adrenal cortical carcinoma, adrenal hyperplasia, and tumor-induced hypercortisolism, mainly by inhibiting adrenal cortical function.Are t···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：254
Mitotaneis a highly potent antineoplastic drug specifically designed to treat inoperable adrenocortical carcinoma and Cushing syndrome.What are the side effects of using Mitotane?T···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：310
Anamoreline is the world's first drug for the treatment of cancer cachexia, which was launched in Japan in 2021; By activating ghrelin receptors, it increases appetite and prom···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：235
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：2272025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4532024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：2342025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：2472025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：2272025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2562025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：2362025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2182025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
